Trending
- When the Old Life Doesn’t Fit but the New One Isn’t Clear Yet
- Sevabertinib Earns Japanese Approval Across All Lines in HER2-Mutant NSCLC
- Evolving Treatment Goals in Relapsed/Refractory Multiple Myeloma
- From Moonshot to Ground Shot: Advancing CNS Metastases Care
- People who live past 110 have an unusual abundance of killer immune cells
- Supercharged “natural killer” cells could be a powerful new cancer weapon
- Shingles vaccine linked to 24% lower dementia risk
- Preparing for Advanced Therapy in Relapsed/Refractory Multiple Myeloma
